United Parcel Service said Tuesday it has agreed to acquire Smartways Logistics, a provider of time-critical courier services for the healthcare sector in Australia and New Zealand, underscoring the extent to which healthcare logistics has become a key strategic growth area for the company.
The planned acquisition, which is expected to close in the first half of 2027, will give UPS (NYSE: UPS) better access to Oceania in the rapidly growing healthcare logistics market, while connecting Smartways customers to UPS’s global transportation network for end-to-end international shipping.
The company has reorganized its business to focus more on high-margin industry verticals with complex logistics needs. UPS has targeted healthcare as a priority growth area, with healthcare logistics projected to grow 6% per year as the pharmaceutical industry continues to develop more sophisticated treatments and healthcare products become more personalized, time-sensitive, and more challenging to move without damage, while increasingly being delivered directly to patients at home. In the third quarter, healthcare revenue at UPS reached $3 billion for the third consecutive quarter, with a run rate for more than $12 billion in healthcare revenue this year.
Smartways is the latest in a series of targeted UPS Healthcare investments. In April 2025, UPS acquired Canada-based Andlauer Healthcare Group, a provider of cold chain logistics services for the healthcare industry. Earlier that year, the freight transportation giant bought Frigo-Trans and sister company BPL, which provide temperature-controlled warehousing and transportation in Europe for pharmaceutical and biotech companies. It also acquired Bomi and MNX.
UPS Healthcare has about 20 million square feet of pharma-certified warehouse space under management, including extensive temperature-controlled facilities. Services include inventory management, cold chain packaging and shipping, storage and fulfillment of medical devices, and lab and clinical trial logistics. In the past two years, UPS invested $48 million to open 27 refrigerated truck cross-dock facilities around the world to meet rising demand from pharmaceutical companies, medical labs and biotech companies for temperature-controlled transport and storage of sensitive products.
UPS said the Smartways deal is part of a broader effort to expand healthcare capabilities in Asia-Pacific. The company has also broader network investments to facilitate more trade flows through its network, including a significantly larger hub at Clark airport in the Philippines and an upgraded air terminal in Seoul, South Korea — both of which have more refrigerated warehouse space for temperature-sensitive pharmaceuticals.
Smartways, which has more than 350 drivers, primarily offers same-day or next-day transport of medical devices and equipment, life sciences products, clinical trials and radiopharmaceuticals for the healthcare industry in Australia and New Zealand. A core business is delivering express freight into hospitals on behalf of medical device and equipment suppliers in key medical verticals and also offers contract logistics to manage inventory and distribution.
Smartways is owned by private equity firm The Riverside Company. Terms of the deal were not disclosed, but The Australian Financial Review on Sunday reported that UPS had offered A$600 million, equivalent to $405 million.
RELATED STORIES:
UPS automates 4 additional facilities ahead of peak shipping season